Dr Mohs is currently Chief Scientific Officer for the Global Alzheimers Platform (GAP) Foundation, a non profit devoted to enhancing the speed and quality of Alzheimers disease research. He also serves as a consultant to academic institutions, foundations and biopharmaceutical companies, and is a member of the Board of Governors for the Alzheimers Drug Discovery Foundation. He retired from Eli Lilly in 2015, where he held leadership positions including Vice President for Neuroscience Early Clinical Development and Leader of the Global Alzheimers Drug Development Team. Before joining Eli Lilly, Dr Mohs spent 23 years with the Mount Sinai School of Medicine where he was Professor in the Department of Psychiatry and Associate Chief of Staff for Research at the Bronx Veterans Affairs Medical Centre. He is a member of the Risk and Compliance Committee.
